| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
59,214
|
65,029
|
38,052
|
39,583
| | Cost of Revenue | 28,520 | 33,606 | 19,511 | 22,415 | | |
Gross Profit
|
30,694
|
31,423
|
18,541
|
17,168
| |
|
Operating Expenses |
|
Research Development | 1,127 | 1,206 | 1,038 | 919 |
|
Selling General and Administrative | 23,573 | 22,557 | 16,805 | 16,848 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
5,994
|
7,660
|
698
|
(599)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (108) | (57) | (98) | (77) |
|
Earnings Before Interest And Taxes | 5,886 | 7,603 | 600 | (676) |
|
Interest Expense | 9 | 10 | 9 | 3 |
|
Income Before Tax | 5,877 | 7,593 | 591 | (679) |
|
Income Tax Expense | 353 | 328 | (625) | (193) |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 5,524 | 7,265 | 1,216 | (486) | |
|
Non-recurring Events |
|
Discontinued Operations | (365) | 6,309 | (265) | 322 |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
5,159
|
13,574
|
951
|
(164)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
5,159
|
13,574
|
951
|
(164)
|
|
0.08(0.92%) 12:30PM EDT - Nasdaq Real Time Price